RS
Rixon Singla
About Rixon Singla
Data last updated:
Rixon Singla has 1 years in corporate governance. Holds Director role. Currently with 2 companies, including Glaxosmithkline Consumer Private Limited and Haleon India Consumer Health Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Glaxosmithkline Consumer Private Limited at ₹675 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Mar 2025 | 2014 | ₹675 Cr (FY 2025) | Active | |
| Director | 03 Mar 2025 | 2014 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rixon Singla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rixon Singla
Rixon Singla has 1 years in corporate governance. Holds Director role. Currently with 2 companies, including Glaxosmithkline Consumer Private Limited and Haleon India Consumer Health Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Glaxosmithkline Consumer Private Limited at ₹675 Cr (FY 2025).
Rixon Singla is associated with 2 companies as Director, including Glaxosmithkline Consumer Private Limited (₹675 Cr), Haleon India Consumer Health Private Limited.
Rixon Singla has expertise in General Business, Healthcare.
Rixon Singla has 1 years in corporate governance.
By reported revenue, the largest current company of Rixon Singla is Glaxosmithkline Consumer Private Limited, with revenue of ₹675 Cr (FY 2025).
Rixon Singla currently holds positions at 2 companies: Glaxosmithkline Consumer Private Limited (₹675 Cr), Haleon India Consumer Health Private Limited.